BLACKSOLVENT STARTUP NEWS | 19.10.26
Show Me the Run Rate
This was the week investors stopped paying for promises and started paying for proof. Ramp raised US$1.85 billion at a US$60 billion valuation while reporting more than US$2 billion in annualised revenue and positive cash flow. Modal crossed a US$1 billion run rate and tripled its valuation in five months. Labelbox said it had reached profitability, Icon said it was on pace for 4x revenue growth, and Suki said revenue had doubled. Around those numbers, the compute layer kept getting deeper: Tenstorrent’s US$1.5 billion Series E and Mueon’s modular chip racks are bets that the Nvidia-shaped stack will not stay the only option. The message for founders is blunt: in late 2026, the biggest cheques follow revenue that can already be seen.
Across the 19 disclosed financings below, companies raised approximately US$5.62 billion. That total is led by Ramp’s US$1.85 billion round and Tenstorrent’s US$1.5 billion Series E, which together account for about 60% of it. It is a selected, disclosure-based snapshot of rounds announced between October 13 and 19, 2026 — not a measure of all global venture activity. For context, Crunchbase News described October 10–16 as a week in which investors scaled back on giant rounds, with just two U.S. startup financings in the multiple hundreds of millions.
Ramp Raises US$1.85 Billion at a US$60 Billion Valuation as Revenue Passes US$2 Billion
BY BLACKSOLVENT NEWS
New York-based Ramp raised US$1.85 billion in primary financing at a US$60 billion valuation, announced on October 15. Dragoneer Investment Group led the round, with Thrive Capital, Founders Fund, Sands Capital and Avenir Growth as co-leads and a long syndicate that includes Fidelity, T. Rowe Price, GIC and Coatue. The valuation is up from US$44 billion in June, and total equity raised now stands at about US$5 billion.
Ramp sells corporate cards, expense management, bill pay and, increasingly, AI tools that monitor and cut model spending. The company says it now exceeds US$2 billion in annualised revenue, is cash-flow positive and serves more than 85,000 businesses moving over US$275 billion in annualised purchase volume. Why it matters: with Brex now inside Capital One, Ramp is the last independent giant in spend management — and it is pricing itself on numbers, not narrative. That makes it a public-market candidate in all but name.
Tenstorrent Raises US$1.5 Billion Series E to Challenge Nvidia’s Stack
BY BLACKSOLVENT NEWS
Santa Clara-based Tenstorrent closed a US$1.5 billion Series E at a US$6.2 billion post-money valuation, announced on October 19. Trace Capital and Innovation X led the financing, joined by ARK Invest, Fidelity, Morgan Stanley, T. Rowe Price, SanDisk and Tether Investments, among others. The valuation is more than double the mark set in its December 2024 round.
Led by chip architect Jim Keller, Tenstorrent builds RISC-V-based AI processors and Galaxy server systems, and licenses its processor IP to chipmakers including Samsung and LG. The capital funds volume manufacturing of Galaxy and international expansion. Why it matters: investors are financing a whole alternative ecosystem — chips, systems, open software and licensable IP. The test is whether developers will move real workloads off the incumbent platform.
Modal Raises US$750 Million Series D After Crossing a US$1 Billion Run Rate
BY BLACKSOLVENT NEWS
New York-based Modal raised a US$750 million Series D at a US$15.75 billion post-money valuation, announced on October 14. Accel led the round, Kleiner Perkins joined as a new investor and existing backers including Menlo Ventures, General Catalyst, Redpoint, Lux Capital and Bain Capital Ventures participated.
Modal runs serverless cloud infrastructure for AI inference, training jobs and code execution. It says annualised run rate has passed US$1 billion, up from just over US$300 million at its May Series C, and that its Sandboxes product — isolated environments where AI agents run code — is a US$300 million run-rate business on its own. Why it matters: valuation more than tripled in five months, and the growth is coming from agents needing somewhere safe to execute. Agent infrastructure is now a revenue line, not a roadmap slide.
OMass Therapeutics Raises US$310 Million Series C for Endocrine and Immunology Drugs
BY BLACKSOLVENT NEWS
Oxford-based OMass Therapeutics raised an oversubscribed US$310 million (£230 million) Series C, announced on October 15. The round was co-led by new investors Bain Capital Life Sciences, Forbion and Novo Holdings, with Janus Henderson, SV Health Investors and Jefferson Life Sciences joining every existing backer, including Syncona, Oxford Science Enterprises and GV.
The company’s OdyssION platform uses native mass spectrometry to find small-molecule drugs against hard targets. Proceeds take its lead candidate, OMS1620, through Phase 2 in congenital adrenal hyperplasia and ACTH-dependent Cushing’s syndrome. Why it matters: OMass describes it as the second-largest European biotech raise of 2026. A cheque this size for a UK spinout is a signal that Britain can build late-stage biotech without first moving to Boston.
Icon Raises US$200 Million Series D to Scale Multi-Storey 3D-Printed Construction
BY BLACKSOLVENT NEWS
Austin-based Icon announced a US$200 million Series D on October 13, co-led by Baillie Gifford and funds managed by BlackRock, with Norwest, Tiger Global and Moderne Ventures among the participants. CNBC reported the round values Icon at US$1.4 billion and lifts total funding to about US$700 million.
Icon builds robotic 3D-printing systems for homes and other structures and has completed more than 270 of them across five states and two countries. The money starts production of Titan, its multi-storey printer, and funds a new R&D facility; its defence and space unit has won over US$370 million in government contracts. Why it matters: Icon says it is on pace for 4x revenue growth this year. Two of the world’s largest long-only investors are betting that printed construction can move from novelty to housing supply.
Soufflé Therapeutics Raises US$135 Million Series B to Reach the Clinic
BY BLACKSOLVENT NEWS
Massachusetts-based Soufflé Therapeutics closed an oversubscribed US$135 million Series B on October 13, led by Juvia Group. New institutional investors TCG Crossover, BB Biotech, Fidelity, Balyasny and an unnamed sovereign wealth fund joined existing backers including Amgen Ventures, ARCH Venture Partners and Leaps by Bayer.
Soufflé’s REMEDY engine delivers RNA medicines to specific cell types outside the liver — a long-standing bottleneck in genetic medicine. The round moves three programmes toward the clinic, led by facioscapulohumeral muscular dystrophy and a heart-failure target. Why it matters: with a US$200 million Series A a year ago, disclosed funding now exceeds US$330 million with no programme yet in humans. Investors are paying up for delivery platforms before the clinical data arrives.
Town Raises US$108 Million Series B at a US$1 Billion Valuation for Team AI Assistants
BY BLACKSOLVENT NEWS
San Francisco-based Town raised a US$108 million Series B at a US$1 billion valuation on October 19, co-led by Forerunner Ventures and Menlo Ventures, with Andreessen Horowitz and First Round Capital participating. The round follows a US$55 million Series A announced at its public launch in June.
Town gives every employee an AI assistant, called a Townie, that connects to email, documents and calendars — and talks to colleagues’ assistants to move work between people. The company says paying teams have grown ninefold since July. Why it matters: unicorn status four months after launch shows investors expect the next AI layer to coordinate teams, not just individuals. Microsoft and Google own the inboxes Town must work inside.
Labelbox Raises More Than US$100 Million Series E and Says It Is Profitable
BY BLACKSOLVENT NEWS
San Francisco-based Labelbox raised more than US$100 million in a Series E at a US$1.25 billion pre-money valuation, announced on October 14. Infinitum Partners led, with Wipro Ventures, Andreessen Horowitz, B Capital, Tau Ventures and Snowpoint Ventures participating. The financing combines equity with a credit facility.
Founded in 2018, Labelbox has moved from data labelling to reinforcement-learning environments for frontier labs and managed AI agents for enterprises. It says it works with about 90% of leading frontier labs and hyperscalers and reached profitability in 2026 while growing more than fivefold. Why it matters: the picks-and-shovels business of AI training has become profitable at scale — a rare claim at Series E.
Estuary Biotherapeutics Launches With US$103 Million for Kidney Gene Therapies
BY BLACKSOLVENT NEWS
Menlo Park-based Estuary Biotherapeutics came out of stealth on October 16 with US$103 million in committed financing, made up of a US$93 million Series A led by RA Capital Management and a previously undisclosed US$10 million seed co-led by 4BIO Capital and GV. Deep Track Capital, Biogen New Ventures and UPMC Enterprises joined the Series A. (Only the US$93 million Series A is counted in this roundup’s total.)
Estuary develops locally delivered gene therapies for autosomal dominant polycystic kidney disease, the most common inherited kidney disorder, affecting more than 8 million people worldwide. It expects its two lead programmes to enter human testing in 2027 and 2028. Why it matters: the kidney has been largely untouched by gene therapy because delivery is hard. Estuary’s bet is that a kidney-confined approach finally solves it.
Dream Labs Launches With a US$90 Million Seed for a Robot Foundation Model
BY BLACKSOLVENT NEWS
San Francisco-based Dream Labs announced a US$90 million seed round on October 19, led by B Capital, with Kindred Ventures, A.Capital, Unusual Ventures, SV Angel and Wing VC participating. It launched Dream API alongside the funding.
Founded by former Nvidia robotics researchers, Dream Labs builds a model that turns camera input and plain-language instructions into robot actions across different hardware, and says it has more than 20 hardware partners. Why it matters: a nine-figure seed shows what physical AI costs before the first customer. If the model transfers across machines, robotics could get a software layer that is independent of who builds the arm.
Suki Raises US$90 Million Series E for Healthcare AI Agents
BY BLACKSOLVENT NEWS
Redwood City-based Suki announced a US$90 million Series E on October 13. Axios reported the round was led by Healthier Capital, with Crosslink Capital and Hercules Capital also joining as new investors. Total funding now exceeds US$250 million; no valuation was disclosed.
Suki began with ambient clinical documentation and now embeds its AI in more than 30 health-technology partners, including athenahealth. It says supported patient encounters grew more than 190% year on year and revenue doubled in 2025. Why it matters: the AI-scribe market is crowded and well funded. Suki is betting that being the engine inside other platforms beats owning every clinician relationship directly.
Abby Care Raises US$82 Million Series C to Pay Family Caregivers
BY BLACKSOLVENT NEWS
San Francisco-based Abby Care closed an US$82 million Series C led by Transformation Capital, Fortune reported on October 15.
The five-year-old company helps family members become certified, paid caregivers who deliver care at home. Why it matters: the U.S. faces a caregiver shortage that no recruiting drive will close. Turning unpaid family care into reimbursed work is one of the few scalable answers — if payers keep funding it.
Stand Raises US$70 Million Series C at a US$1 Billion Valuation for Disaster-Resilient Home Insurance
BY BLACKSOLVENT NEWS
San Francisco-based Stand raised a US$70 million Series C at a US$1 billion valuation on October 15, led by Saga Ventures, with Lowercarbon, Eclipse, Equal Ventures, Inspired Capital, Neotribe and Jackson Square Ventures participating. Total funding is now about US$130 million.
Stand simulates how individual homes would fare in wildfires and hurricanes, recommends upgrades and insures properties that meet its standard, with discounts it says can reach 70%. It now insures more than US$10 billion of property, up from US$1 billion a year ago. Why it matters: incumbents are retreating from California and Florida. Stand is betting that pricing physics, not zip codes, makes those markets insurable again.
Mueon Raises US$65 Million Series A for Modular AI Computing Blocks
BY BLACKSOLVENT NEWS
Portland-based Mueon raised a US$65 million Series A on October 15, led by Maverick Silicon, with Intel Capital, IQT, Oregon Venture Fund, M-Ventures, Wellington Capital and others participating. Total funding now exceeds US$80 million.
Mueon’s Cubelets are stackable blocks that combine compute, memory, interconnect, power and cooling, aiming at up to 10x gains in power and cost efficiency within the same rack. Those gains are company targets, not yet independently verified. Why it matters: as data centres hit power and space limits, the packaging of chips is becoming as important as the chips themselves.
North.cloud Raises US$60 Million Series B to Control Runaway Cloud and AI Spend
BY BLACKSOLVENT NEWS
New York-based North.cloud raised a US$60 million Series B on October 15, led by PeakSpan Capital, with Litquidity Ventures, Companyon Ventures and others participating. Axios reported total funding of US$67 million.
North.cloud consolidates spend across AWS, Azure, Google Cloud, AI models and data platforms, and automates the fixes. Why it matters: AI budgets are the fastest-growing line on many IT bills, and finance teams want someone watching the meter. Ramp’s own AI-cost tools show how contested this category is becoming.
ZAP Surgical Secures US$36 Million to Expand Non-Invasive Brain Radiosurgery
BY BLACKSOLVENT NEWS
San Carlos-based ZAP Surgical Systems secured US$36 million on October 19, led by Catalio Capital Management, with continued support from Chinese strategic partner Baheal. The round type was not disclosed.
Founded by neurosurgeon John Adler, ZAP makes ZAP-X, a self-shielded radiosurgery system for brain tumours and other lesions. The company says it has shipped 50 systems and treated nearly 10,000 patients. Why it matters: removing the need for a radiation vault opens radiosurgery to hospitals that could never justify the construction cost.
Tolan Raises US$30 Million to Turn AI Companions Into Assistants
BY BLACKSOLVENT NEWS
San Francisco-based Tolan raised US$30 million on October 19, led by Union Square Ventures, with Khosla Ventures participating. The round type was not disclosed.
Tolan makes animated AI characters that remember users and are now handling everyday tasks such as meal planning. USV says the app logged more than 70 million conversations in the past year. Why it matters: engagement-first consumer AI is getting funded, but the business still has to prove that companionship converts into paid usefulness.
RapidCanvas Raises US$29 Million Series B for Built-For-You Enterprise AI Apps
BY BLACKSOLVENT NEWS
Austin-based RapidCanvas raised a US$29 million Series B on October 16, led by Vertex Ventures SEA & India, with Hitachi Ventures and existing investors Accel and Peak XV Partners participating. Total funding is now US$52.5 million.
RapidCanvas pairs an AI agent platform with its own engineers to build and run business applications for companies. Why it matters: plenty of enterprises want AI apps but lack the teams to build them. Services wrapped around software is becoming a credible way to sell AI to the mid-market.
Prism Data Raises US$20 Million Series A for Cash-Flow Credit Underwriting
BY BLACKSOLVENT NEWS
New York-based Prism Data raised a US$20 million Series A on October 19, led by Story Ventures, with FINTOP Capital, Core VC and Obvious Ventures participating. Total funding now exceeds US$25 million.
Prism scores borrowers using bank-transaction histories rather than credit files alone, and says three of the five largest U.S. fintech lenders use its models. Why it matters: cash-flow underwriting can widen access for gig workers and thin-file borrowers — provided the models clear fair-lending scrutiny.
The forward-looking takeaway is that revenue has become the price of admission for a megaround. The week’s largest cheques went to companies that could put a number on the table — Ramp’s US$2 billion in annualised revenue, Modal’s US$1 billion run rate, Labelbox’s profitability, Icon’s 4x growth pace. Underneath them, investors kept funding the infrastructure those businesses run on: alternative AI chips, modular racks and the cloud-spend tools that keep AI bills in check. Biotech supplied the week’s other large rounds, with OMass, Soufflé and Estuary all raising on delivery platforms rather than late-stage data. For founders, the playbook is clear: show the run rate, or show the platform that every run rate will depend on. Expect the next few weeks to test whether the rest of the AI application layer can post numbers like Ramp’s — or whether valuations start to separate the earners from the storytellers.
Written by Blaksolvent News
Research note: Deal facts were compiled from Crunchbase News, TechCrunch, Reuters, Fortune, Axios, Fierce Biotech, Fierce Healthcare, Healthcare Dive, BioPharm International, Tech Startups, Pulse 2.0, Artemis and company press releases published October 13–19, 2026. Labelbox is counted at its US$100 million floor (“more than US$100 million”), which includes a credit facility; Estuary is counted at its US$93 million Series A, excluding its previously raised seed; Suki’s round was first reported by Axios on October 12 and formally announced on October 13. Neolix’s reported US$400 million Series E (October 20) falls outside this window and will be covered next week. Where a lead investor or round type was not named in public reporting, this is stated rather than inferred.

Blacksolvent
Sources: Crunchbase News — The Week’s 10 Biggest Funding Rounds (Oct 10–16) · TechCrunch — Ramp · Tech Startups — Oct 20 roundup (Tenstorrent, Town, Dream Labs, ZAP, Tolan, Prism) · Goodwin — OMass Series C · Fortune — Stand · Fierce Biotech — Estuary · Healthcare Dive — Suki · Construction Dive — Icon · The Next Web — RapidCanvas · Seedtable — North.cloud